Families battle insurance over world’s most expensive drug

The drug, Zolgensma, is a life-saving, single-dose gene therapy that treats children with spinal muscular atrophy or SMA, a disease that takes away the ability to walk, breathe and eat. Two months after the FDA approved it, families across the country say they’re being denied access to the drug because insurance refuses to pay.July 26, 2019